Table II.
Mean Demographic and Baseline Characteristics of IRMAII*
| Total number of patients | 611 |
| Age in years | 59 |
| Male/female | 68%/32% |
| Duration of diabetes | 10 years |
| Screening seated blood pressure | 153/90 mm Hg |
| Duration of hypertension | 7 years |
| Albumin excretion rate | 71 µg/min |
| Serum creatinine | 1.2mg/dL |
| Glycosylated hemoglobin (HbA1c) | 7.2% |
| Body mass index | 30 kg/m2 |
| Substudy Analysis | |
| Number of patients | 132 |
| Glomerular filtration rate | 131 ml/min |
| Glomerular filtration rate | 112 ml/min/1.73 m2 |
| Extracellular volume† | 17.58 L |
| *Based on all randomized patients; †based on 121 patients. IRMA II=Irbesartan Microalbuminuria II trial | |